← Volver a los resultados de búsquedaPerfil del inversor:
Perfil del inversor:
OrbiMed
Dirección:New York, New York, United States
País:
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Total de acuerdos: 223
Como inversor principal: 111
También como inversor secundario: 10
Como segundo inversor: 174
September 24, 2025$95mSegundo inversor
September 24, 2025
$95m
Sparrow Pharmaceuticals Raises $95M in Series B Financing
Segundo inversor
Sparrow Pharmaceuticals Raises $95M in Series B Financing
September 22, 2025$60mInversor principal
September 22, 2025
$60m
Avenzo Therapeutics Raised $60M in Series B Funding
Inversor principal
Avenzo Therapeutics Raised $60M in Series B Funding
September 8, 2025$60mSegundo inversor
September 8, 2025
$60m
Epigenic Therapeutics Closes $60M Series B Financing
Segundo inversor
Epigenic Therapeutics Closes $60M Series B Financing
September 4, 2025$32mInversor principal
September 4, 2025
$32m
Congruence Therapeutics Raises $32M in Funding
Inversor principal
Congruence Therapeutics Raises $32M in Funding
September 2, 2025
September 2, 2025